Cardio Diagnostics Holdings, Inc.
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 311 W. SUPERIOR STREET, CHICAGO, IL, 60645
Mailing Address 311 W. SUPERIOR STREET, CHICAGO, IL, 60645
Phone 855-226-9991
Fiscal Year End 1231
EIN 870925574
Financial Overview
FY2025 FY
$35K
Revenue
$10.62M
Total Assets
$1.06M
Total Liabilities
$9.56M
Stockholders' Equity
-
Cash & Equivalents
$-3.71
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 13, 2026 | View on SEC |
| 8-K Current report of material events | February 19, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 6, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | October 15, 2025 | View on SEC |
| 4 Insider stock transaction report | October 3, 2025 | View on SEC |
| 4 Insider stock transaction report | October 3, 2025 | View on SEC |
Annual Reports
10-K March 13, 2026
- Strong revenue growth of 87.5% to $1.5 million in 2024, reflecting initial commercialization success.
- Flagship products Epi+Gen CHD™ and PrecisionCHD™ offer advanced epigenetic and genetic testing for personalized heart disease risk assessment.
Related Companies
Companies in the same industry (SIC: 2835)
IMMUCELL CORP /DE/
ICCC In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
ACHIEVE LIFE SCIENCES, INC.
ACHV In Vitro & In Vivo Diagnostic Substances
Q/C TECHNOLOGIES, INC.
QCLS In Vitro & In Vivo Diagnostic Substances
MYRIAD GENETICS INC
MYGN In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.